Pharmacists

A new paper published in JAIDS finds that pharmacists could play a key role in providing long-acting injectable pre-exposure prophylaxis (PrEP) for HIV prevention. In a mixed methods analysis of survey and interview data, CHPRC researchers found that many pharmacists would be willing to administer injectable PrEP if provided with training, compensation, and a private room. However, pharmacists may require additional resources and policy support to make widespread implementation feasible.

In February 2024, Senate Bill 339 was signed into law to help realize the goal of widespread access to HIV pre- and post-exposure prophylaxis (PrEP and PEP) in California pharmacies. This fact sheet explains key changes under Senate Bill 339 that may reduce previously-identified barriers to pharmacist delivery of PrEP/PEP.